CA2457876C - Process for the preparation of activated polyethylene glycols - Google Patents

Process for the preparation of activated polyethylene glycols Download PDF

Info

Publication number
CA2457876C
CA2457876C CA2457876A CA2457876A CA2457876C CA 2457876 C CA2457876 C CA 2457876C CA 2457876 A CA2457876 A CA 2457876A CA 2457876 A CA2457876 A CA 2457876A CA 2457876 C CA2457876 C CA 2457876C
Authority
CA
Canada
Prior art keywords
group
chr1
polyethylene glycol
formula
chr4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2457876A
Other languages
French (fr)
Other versions
CA2457876A1 (en
Inventor
Marie-Pierre Faure
Michel Ibea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RBA Pharma Inc
Original Assignee
RBA Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RBA Pharma Inc filed Critical RBA Pharma Inc
Publication of CA2457876A1 publication Critical patent/CA2457876A1/en
Application granted granted Critical
Publication of CA2457876C publication Critical patent/CA2457876C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Abstract

The present invention relates to a process for the preparation of activated polyethylene glycols, or PEG(NPC)2s, comprising reacting polyethylene glycol with an activator while in the presence of an aromatic nitrogen containing heterocyclic base. The process is carried out at temperatures ranging from about 20 to about 30 ~C, more preferably at room temperature, and under stoichiometric conditions.

Description

PROCESS FOR THE PREPARATION OF ACTIVATED POLYETHYLENE GLYCOLS

TITLE OF THE INVENTION

Process for the Rapid Preparation of Activated Polyethylene Glycols [PEG-(NPC)2].

FIELD OF THE INVENTION

The present invention relates to a process for the rapid preparation .of activated polyethylene glycols, or PEG(NPC)2s. More specifically, the present invention is concerned with a process for the preparation of activated PEGs involving shorter reaction times, lower, reaction temperatures and allowing for the expeditious recovery of the activated PEGs by a simple extraction procedure. Additionally, the present invention relates to a process for the preparation of activated PEGs wherein stoichiometric amounts of reagents are used. The invention further covers the activated PEGs produced by this rapid process and their use in a variety of pharmaceutical, medical, cosmetical and chemical applications.

BACKGROUND OF THE INVENTION

Polyethylene glycol (PEG) is a polymer having the structure H(O-CH2CH2-)õOH.
It is generally synthesized by the ring opening polymerization of ethylene oxide..
While the polymer usually has a linear structure at molecular weights _< 10 kD, the higher molecular weight PEGs may have some degree of branching.' Polyethylene glycols of different molecular weights have previously been used in a number of applications, including to increase the solubility of drugs.
During the last three decades, polyethylene glycol has been extensively investigated for delivery of various proteins via parenteral routes. Generally, PEGs have been most widely used for the delivery of both traditional drugs (small molecules) and proteins/enzymes in.the treatment of cancer.

Several chemical procedures have been developed for the preparation of activated PEGs, which can then be used to react specifically with free amino groups on an enzyme's surface, under mild aqueous conditions. PEGs have been successfully activated by reaction with 1,1-carbonyl-di-imidazole, cyanuric chloride, tresyl chloride, 2,4,5-trichiorophenyl chloroformate or 4-nitrophenyl chloroformate, various N-hydroxy-succinimide derivatives as well as by the Moffatt-Swern reaction.2"10 In most cases, the activating agent acts as a linker between the PEG and the enzyme or protein.

One of the major disadvantages encountered with the processes currently available involves the reaction temperatures at which the activation reactions are carried out. The most commonly used solvents are acetonitrile (CH3CN) and dichloromethane (CH2CI2), containing small volumes of a co-solvent, usually triethylamine (TEA). Usually, the activation reactions are carried out under refluxing conditions at a temperature of about 84 C when acetonitrile is used, or at a temperature of about 40 C when dichloromethane is chosen as the solvent.
Several crystallization steps are commonly required for the isolation and purification of the activated PEG product. Such steps can make currently available processes for the activation of PEGs inconvenient.

The activation of PEGs with 4-nitrophenyl chloroformate, to generate PEG-di-nitrophenyl carbonates, has been described by Fortier and Laliberte.10 The reactions were carried out in acetonitrile containing triethylamine (TEA) over a period of 5 hours at 60 C. The long reaction times and the reaction temperatures required to perform the activation reactions are major disadvantages of this process. Additionally, in order to keep the system as anhydrous as possible, the use of a cumbersome soxhlet is required. This imparts a severe limitation on the activation process, especially when transposed on a larger scale.

There is thus a need for a. low-cost process for the activation of PEGs that is time efficient and that can be performed at room temperature. There is also a need for a process allowing for the rapid isolation and purification of the activated PEGs.
Moreover, there is a need for a process for PEG activation that is amenable to large-scale production.

The present invention seeks to meet these and other needs.
SUMMARY OF THE INVENTION

The present invention relates to a novel process for the activation of PEGs that is characterized by improved reaction efficiency and improved reaction conditions.
The present invention relates to a novel process for the activation of PEGs that is characterized by the use of stoichiometric amounts of reagents and that provides.
a very high degree of activation.

The present invention also relates to a novel process for the activation of PEGs that is further characterized by low manufacturing costs and that is easily amenable to large scale production.

In addition, the present invention relates to a novel process for the isolation and purification of the produced activated PEGs, characterized by an efficient extraction and precipitation procedure.

According to one aspect of the present invention, there is provided a process for preparing activated polyethylene glycols (PEGs), comprising reacting polyethylene glycol (PEG) with an activator in the presence of an aromatic nitrogen-containing heterocyclic base, wherein the activator has the general structure Y-Q-X and may be selected from, but is not limited to, the group consisting of CISO2CI, CICOCH2SO2CI, 4-O2NPh000CI, 2-O2NPh000CI, PhOCOCI, CISO2CH2CH2SO2CI, POCI3, PhOPOCl2, PhPOCl2, CCI3000I, CBr3000I, and XbPhOCOCI wherein X and Y may be identical or different and represent an electron withdrawing group, and wherein "b" is an integer ranging from 1 to 3.

3a According to another aspect, there is provided a process for preparing a bis-activated polyethylene glycol having the formula:

Y-Q-O-(C H2-C H2-O) n-Q-Y
wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting of SO2, CO(CHR,)tSO2, CO-0-(CHR,)t-O-SO2r C(O), SO2(CHR,)tSO2, S02-0-(CHR,)t-O-S02, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO-, and S02-O-(CH R, )t-CR2=CR3-(CH R4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;
the process consisting essentially of reacting under stoichiometric conditions a polyethylene glycol having the formula:

H-(O-CH2-CH2-)õ-OH
wherein n is an integer between 4 and 800;

with an activator having the formula of Y-Q-X;
wherein X and Y independently are selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxy group; and Q is selected from the group consisting Of S02, CO(CHRI)tSO2, CO-O-(CHR,)t-O-SO2, C(O), SO2(CHR,)tSO2i S02-O-(CHR,)t-O-S02, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO- , and S02-O-(CHR,)t-CR2=CR3-(CHR4) t-0-SO2i wherein t is 1, 2, or 3; and 3b R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

N

(NR5R6)0 wherein (NR5R6), is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.

According to another aspect, there is provided a process for preparing a bis-activated polyethylene glycol having the formula:

Y-Q-O-(CH2-CH2-0)nQ-Y
wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting of SO2, CO(CHR,)tSO2, CO-O-(CHR,)t-0-S02, C(O), S02(CHR,)tSO2, S02-O-(CHR,)t-O-SO2, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO-, and S02-0-(CHR,)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;
the process consisting essentially of reacting a polyethylene glycol having the formula:

3c H-(O-CH2-CH2-),-0H

wherein n is an integer between 4 and 800;

with an activator having the formula of Y-Q-X;
wherein X and Y are different and independently selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of S02, CO(CHR,)tSO2, CO-O-(CHR,)t-O-SO2, C(O), S02(CHR,)tSO2, S02-O-(CHR,)t-O-SO2, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO-, and S02-O-(CH R, )t-CR2=CR3-(CH R4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

N

(NR5R6)0 wherein (NR5R6)I is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.

According to another aspect, there is provided a process for preparing a bis-activated polyethylene glycol having the formula:

3d Y-Q-O-(CH2-CH2-0)n Q-Y

wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting of SO2, CO(CHR,)tSO2, CO--O-(CHR,)t-O-S02, C(O), SO2(CHR,)tSO2, S02-O-(CHR1)t-O-SO2r CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO- , and S02-O--(CH R, )t-CR2=CR3-(C H R4)t-O-S O2 wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

the process consisting essentially of reacting a polyethylene glycol having the formula:
H-(O-CH2-CH2-),f-OH

wherein n is an integer between 4 and 800;
with an activator having the formula of Y-Q-X;
wherein X and Y independently are selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group, provided that at least one of X and Y
is a halide group; and Q is selected from the group consisting of SO2, CO(CHR,)tSO2r CO-0-(CHR,)t-O-S02, C(O), SO2(CHR,)tSO2r S02-O-(CHR,)t-O-S02, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO- , and S02-O-(CHR,)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

3e in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

N

(NRsR6)c wherein (NR5R6)I is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.

According to another aspect, there is provided a process for preparing a bis-activated polyethylene glycol having the formula:

Y-Q-O-(C H 2-C H 2-0)õQ-Y
wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting of SO2, CO(CHR,)tSO2, CO-O-(CHR,)t-0-SO2i C(O), S02(CHR,)tSO2, S02-O-(CHR,)t-O-SO2, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO-, and S02-O-(CHR,)t-CR2=CR3-(CHR4)t -0-SO2i wherein t is 1, 2, or 3; and R,, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

the process consisting essentially of reacting a polyethylene glycol having the formula:
H-(O-CH2-CH2-),j--OH

wherein 3f n is an integer between 4 and 800;

with an activator having the formula of Y-Q-X;
wherein X and Y independently are selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of S02, CO(CHR,)tSO2, CO-0-(CHR1)t-0-SO2, C(O), SO2(CHR,)tSO2i SO2-O-(CHR,)t-O-SO2, CO-O-(CHR,)t-CR2=CR3-(CHR4)t-O-CO-, and S02-O-(CHR,)t-CR2=CR3-(CHR4)t -0-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

at a temperature range between about 20 C. and about 30 C., and in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

N

(NR5R6)0 wherein (NR5R6)I is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.
Unless defined otherwise, the scientific and technological terms and nomenclature used herein have the same meaning as commonly understood by a person of ordinary skill. Generally, procedures such as extraction, precipitation and recrystallization are common methods used in the art. Such standard techniques can be found in reference manuals such as for example Gordon and Ford (The Chemist's Companion: A handbook of Practical Data, Techniques and References, John Wiley & Sons, New York, NY, 1972).

The present description refers to a number or routinely used chemical terms.
Nevertheless, definitions of selected terms are provided for clarity and consistency.

As used herein, the expression "aprotic solvent", refers to a solvent that does not possess an acidic proton.

As used herein, the expression "electron withdrawing group", refers to a substituent on an aromatic ring that withdraws electrons from the aromatic ring by inductive effects and/or by resonance effects.

As used herein, the term "about" refers to a +/- 5% variation from the nominal value.

As used herein, the formula PEG(NPC)2, refers to a polyethyleneglycol, bis activated with a 4-Nitro-Phenyl Carbonate group.

Further scope of applicability will become apparent from the detailed description given hereinafter. It should be understood, however, that this detailed description, while indicating preferred embodiments of the invention, is given by way of illustration only, since various changes and modifications will become apparent to those skilled in the art.
BRIEF DESCRIPTION OF THE DRAWINGS

Figure 1 represents a block diagram depicting the degree of PEG activation in processes using DMAP and TEA respectively, with 4-nitrophenyl chloroformate as the activator, and using stoichiometric amounts of all reagents. The activation 5 reactions were carried out in CH2CI2 at room temperature.

Figure 2 represents a block diagram depicting the yields of activated PEG
produced by both the DMAP and the TEA processes using 4-nitrophenyl chloroformate as the activator and using stoichiometric amounts of all reagents.
The activation reactions were carried out in CH2CI2 at room temperature.

Figure 3 represents a block diagram depicting the degree of gelification of the activated PEGs produced by both the DMAP and TEA procedures using 4-nitrophenyl chloroformate as the activator and using stoichiometric amounts of all the reagents. The activation reactions were carried out in CH2CI2 at room temperature.
DETAILED DESCRIPTION OF THE INVENTION
In a broad sense, the present invention provides a novel process for the activation of PEGs that is characterized by improved reaction times and reaction conditions, and that is easily amenable to large scale production while maintaining low manufacturing costs.

The activation of PEG using various activating agents while in the presence of an aromatic nitrogen containing heterocyclic base, more specifically dimethylaminopyridine (DMAP), was investigated. The activation reactions were carried out in an aprotic solvent system, preferably composed of methylene chloride (CH2CI2). The activation reactions were carried out using stoichiometric amounts of PEG, an activating agent such as 4-nitrophenyl chloroformate, and 4-DMAP, and were performed at temperatures ranging from about 20 to about 30 C and more preferably at room temperature.

The aprotic solvent used in the present invention is selected from the group consisting of DMSO, DMF, acetonitrile, nitromethane, HMPA, acetone, acetic anhydride, pyridine, o-dichlorobenzene, chlorobenzene, benzene, toluene, xylene, methylene chloride, carbon tetrachloride, THF, dioxane, ethyl acetate, DME, and carbon disulfide. These aprotic solvents have a boiling point ranging from about 35 C to about 230 C.

The only significant side product generated in the activation process, is the hydrochloric acid salt of DMAP. This salt can be efficiently removed from the reaction mixture by simple extraction and filtration procedures. This straightforward purification procedure allows for the isolation of a very pure activated PEG product. Note that while the reaction is carried out under stoichiometric conditions, any unreacted reagent can also removed from the reaction mixture by the above mentioned purification procedures.
The PEG activation process of the present invention can be adequately described by the following general reaction sequence:

M-(O-CH2-CH2-)n-OM + 2 Y-Q-X + aW-T Y-Q-O-(CH2-CH2-0)n-Q-Y + aW-T.MX
PEG entity Activator Base Activated PEG

Equation 1 wherein M represents a hydrogen atom or an atom selected from the group consisting of Li, Na, K, Rb, and Cs and wherein "a" is an integer preferably ranging from 0 to 6 and more preferably ranging from 0 to 2.

The activator Y-Q-X is capable of the in situ generation of ions including, but not limited to, acylium, sulfonium, sulfurylium and phosphonium; X and Y can be H, Cl, Br, I or other leaving groups including but not limited to mesylates, tosylates and phenoxides; both X and Y can be identical or different and "n" is an integer ranging from 4 to 800 and more preferably from 65 to 800 i.e. a PEG molecular weight ranging from 3 000 to 35 000 Da.; and Q can be part of, but is not limited to, the group consisting of -SO2-, -CO(CHR1)tSO2-, -CO-, -SO2(CHR1)tSO2-, -S02-O-(C HR1)t-O-SO2, >PO, -CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO-, and -S02-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2-, wherein "t" is an integer ranging from 1 to 3 and wherein R1, R2, R3 and R4 are either identical or different and are selected from the group consisting of hydrogen, lower alkyl, lower branched alkyl, aryl and aralkyl. More preferably, R1i R2, R3 and R4 are selected from the group consisting of hydrogen, methyl, ethyl, isopropyl and propyl. More preferably, Q
can be part of, but is not limited to, the group consisting of -SO2-, -CO-O-CH=CH-CH2-O-CO-, COCH2SO2-, -CO-, and -SO2CH2CH2SO2-.
In one particular embodiment, the process for preparing a bis-activated polyethylene glycol comprises reacting polyethylene glycol with an activator under stoichiometric conditions in the presence of dimethylaminopyridine (4 - DMAP) as illustrated by equation 1A
Wow.
H(O-CH2-CH2)- OH + 2Y-Q-X + 2W -T = Y-Q-O(CH2-CH2-O)õ-Q-Y + 2W-T, HX
Equation 1A

wherein polyethylene glycol has the formula H (O-CH2-CH2)n-OH
the activator has the formula Y-Q-X, wherein X and Y independently are selected from the group consisting of Cl, Br, I, mesylates, tosylates and phenoxides, and Q is selected from the group consisting of -SO2-, -C(O)-, -C(O)(CHR,)rS02-, -S02(CHR1)tSO2-, -S020(CHR1)tOSOz-, -C(O)-0-(CHR,)r-CR2=CR3-(CHR4)r-0-C(O)-, and -SO2-0-(CHR,)f-CR2=CR3--(CHR4 r-O-SO2-;
wherein R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and t is an integer ranging from 1 to 3; and dimethylaminopyridine (4 - DMAP) has the formula W - T

the bis-activated polyethylene glycol has the formula Y-Q-O-(CH2-CH2--0)n-Q-Y, wherein Y and Q are as defined above, and n is an integer ranging from 4 to 800.

Selected examples of preferred activators (Y-Q-X) include, but are not limited to the following:

EXAMPLE 1:
CI-CO-O-Ph-NO2 wherein, based on Formula 1 (no = 1; ni = n2 = n3 = n8 = 0; p = 1; m = q = 0), Q =
Uo = -CO- and wherein X = Cl and Y = -OPh-NO2 (4-nitrophenoxy).
EXAMPLE 2:

wherein, based on Formula 1 (no = n1 = n3 = n8 = 1; n2 = 2; p = 1; m = q = 0;
Uo =
U1 = SO2; Qo = Q1 = 0 (oxygen); R1 = H), Q = -S02-O-CH2-CH2-O-SO2- and wherein X = Y = Cl.

EXAMPLE 3:
Cl-S02-O-CH2-CH2-O-CO-CI
wherein, based on Formula 1 (no=n1=n2=n6=n7=n8=1; n3=0;p=q=1;m = 0; UO = SO2; U1 = -CO-; Qo = Q3 = 0 (oxygen); R1 = R4 = H), Q = -SO2-O-CH2-CH2-O-CO- and wherein X =Y =CI.

EXAMPLE 4:
CI-CO-O-CH2-CH=CH-CH2-O-CO-CI
wherein, based on Formula 1 (no = n1 = n2 = n4 = n6 = n7 = n8 = 1; n3 = n5 =
0; p =
m=q= 1;Uo=U,=-CO-;Q0=Q3=0 (oxygen); R1=R2=R3=R4=H),Q=-CO-O-CH2-CH=CH-CH2-O-CO- and wherein X = Y = Cl.

Other examples of activators include but are not limited to the following:
CISO2CI, CICOCH2SO2CI, 2-02NPh000CI, PhOCOCI POCI3, PhOPOCl2, PhPOCl2, CCI3000I, CBr3000I, and ZbPhOCOCI wherein Z is selected from the group consisting of Cl, Br, I, and -CN, and wherein "b" is an integer ranging from 1 to 3.

The activation process can be carried out in the presence of an aromatic nitrogen containing heterocyclic base having the general structure shown below in Formula 2:
N
W-T = I (NR5R6)c The NR5R6 substituent can be either in the ortho or para position (2- or 4-position) and R5 and R6 are identical or different and are selected from the group consisting of a lower straight alkyl chain, a lower branched alkyl chain, an aryl group and an aralkyl group, and wherein "c" is an integer equal to either 0, 1 or 2. R5 or R6 can 5 also constitute a solid support similar to those used in peptide synthesis.
More specifically, R5 or R6 is a solid support selected from the group consisting of amino methyl resin, p-alkoxybenzyl alcohol resin, benzhydrylamine resin, hydroxymethyl resin, 4-hydroxymethyl-benzoyloxymethyl resin, Merrifield resin, Sasrin resin, 4-methyl-benzhydrylamine resin. Additionally R5 or R6 can also be a 10 solid support composed of polystyrene-divinylbenzene. Preferably, R5 and R6 are selected from the group consisting of methyl, ethyl, propyl, isopropyl and benzyl.
The aromatic nitrogen-containing heterocyclic base, as defined above in Formula 2, is not used (a = 0), when M in the PEG entity is an atom selected from the group consisting of Li, Na, K, Rb, and Cs. It can also be used as a catalyst (0.01 <_ a 5 1.5) at reaction temperatures ranging from about 20 to about 30 C, more preferably at room temperature, in mixtures comprising stoichiometric quantities of a tertiary amine base, selected from the group consisting of TEA, TIA, DIEA
and 4-methyl morpholine.

In accordance with the present invention, there is therefore provided an activated PEG having the general structure as depicted in Formula 3:
Y-Q-O-(CH2-CH2-O),-Q-Y

Formula 3 wherein Q is selected from, but not limited to, the group consisting of -S02-, -COCH2SO2-, -SO2CH2CH2SO2-; -CO-O-CH2-CH=CH-CH2-O-CO- and -CO-; Y is selected from, but not limited to, the group consisting-of CI and 4-O2NPhO-;
and wherein "n" is an integer ranging from 4 to 800 i.e. a PEG having a molecular weight from 200 to 35 000 Da.

In one preferred embodiment of the present invention, there is provided an activated PEG as described by Formula 4, wherein Y is Cl, Q is -SO2- and "n"
is an integer ranging from 4 to 800 i.e. a PEG having a molecular weight from 200 to 35 000 Da. Preferably, at least one embodiment is represented by the structure in Formula 4:

O

1ooci 11 CI Formula 4 In another preferred embodiment of the present invention, there is-provided an activated PEG as described by Formula 5, wherein Y is Cl, Q is -COCH2SO2- and "n" is an integer ranging from 4 to 800 i.e. a PEG having a molecular weight from 200 to 35 000 Da. Preferably, at least one embodiment is represented by the structure in Formula 5:

jI o ils~
s~. \O I) ci ~II n O
o Formula 5 In yet another preferred embodiment of the present invention, there is provided an activated PEG as described by Formula 6, wherein Y is Cl, Q is -SO2CH2CH2SO2-and "n" is an integer ranging from 4 to 800 i.e. a PEG having a molecular weight from 200 to 35 000 Da. Preferably, at least one embodiment is represented by the structure in Formula 6:
o 0 ~Is~~ll o ~s~~ll~a C1 II s~ ~o II s 0 11' n O II

Formula 6 In still another preferred embodiment of the present invention, there is provided an activated PEG as described by Formula 7, wherein Y is 4-O2NPhO-, Q is -CO-and "n" is an integer ranging from 4 to 800 i.e. a PEG having a molecular weight from 200 to 35 000 Da. Preferably, at least one embodiment is represented by the structure in Formula 7:

NO

O

O O f Formula 7 The activated polyethylene glycols are susceptible of reacting with functional groups selected from the group consisting of hydroxyl groups, amine groups and thiol groups, resulting in the formation of bio-polymers. The functional groups are derived from peptides, proteins, saccharides, polysaccharides, and oligonucleotides. The bio-polymers are used in chemical, food, cosmetical, cosmeceutical, pharmaceutical and dermopharmaceutical applications.
One preferred activation process using 4-DMAP and 4-nitrophenylchloroformate is adequately described by the reaction sequence shown below,in Scheme 1:

0~,,/CI N
H-(O-CH2-CH2-)n-OH + 2 / O II +2 PEG N02 4-nitrophenyichloroformate H CCH

R.T.

O O
~O O
I n 2 4-DMAP.HCI
Scheme 1.

5. The role of 4-nitrophenyl chloroformate is to readily react with the PEG
substrate, resulting in an activated PEG that can be further employed, for example, in reactions with enzyme surfaces. It was selected as the activating agent mainly because of its propensity to minimize side reactions.

The primary function of 4-DMAP is to aid in the activation process. It is assumed that it rapidly provides for a more reactive intermediate, believed to be an acylium ion, by reacting with 4-nitrophenyl chloroformate. This fleeting acylium intermediate then readily reacts with PEG in the course of an activation reaction taking place at room temperature under stoichiometric conditions, to produce the activated PEG in only 2 hours of reaction time. The secondary function of 4-DMAP is to act as an acid scavenger, that is, to form a salt by complexing with the hydrochloric acid (HCI) produced in the activation reaction. The scavenging of HCI by 4-DMAP is an important step in the reaction sequence, since the presence of HCI could lead to a great number of unwanted side reactions which, in turn, will have a detrimental effect on the overall efficiency of the activation reaction.

The activation of PEG using a tertiary amine base such as triethylamine (TEA) was also investigated under identical reaction conditions as those employed in the DMAP process i.e. at room temperature over a period of 2 hours, and compared with the DMAP activation process. It was observed that even though 4-nitrophenyl chloroformate was again chosen as the activating reagent, the activation process required the use of a 3-fold excess of TEA and could no longer be performed at room temperature. Activation of PEG was achieved by refluxing the reaction mixture in acetonitrile (80 C) over a period of 8 hours.

The activation of PEGs using TEA is less attractive than the process using DMAP
because of the requirement for refluxing, which necessitates constant supervision. Additionally, refluxing procedures inherently require additional materials, such as reflux condensers or a soxhlet set-up. When the activation reactions are carried out on a larger scale, this additional glassware can rapidly become unwieldy and very expensive. The additional energy requirement is also a factor that cannot be ignored.

Another preferred activation process utilizing sodium PEGylate and 4-nitrophenylchloroform ate is adequately described by the reaction sequence shown below in Scheme 2:

, o a /
Na-(O-CH2-CH2-)n ONa + 2 Y
5 ~ I

PEGylate NO2 4-n itrophenyl chloroformate 10 R.T.

O
~O 0 I
n ~ O
15 N02)[::' 2 NaCI
Scheme 2 The activation process is easily carried out by first preparing the sodium PEGylate, and then reacting the PEGylate with 4-nitrophenyichloroformate.

The use of excess reagents has repercussions on the isolation and purification steps of the activation process, since these reagents will have to be removed from the activated PEG product. The reaction mixture, upon completion of the TEA-induced activation process, is mainly composed of activated PEG, unreacted TEA and 4-nitrophenyl chloroformate, as well as the hydrochloric acid (HCI) salt of TEA. In previously described processes, the isolation of the activated PEG
product required several precipitation or crystallization steps before a relatively pure product was obtained. A direct comparison between the DMAP, the TEA and the sodium PEGylate activation procedures is shown in Table 1.

Table 1: Direct comparison of. the DMAP, the TEA, and the PEGylate induced activation process.
Comparative DMAP procedure TEA"procedure PLGylate procedure elements Nitrogen base DMAP (4-DMAP) TEA No nitrogen base Structure Pyridine family Tertiary amine NA
Reaction set-up Beaker with stirrer Reflux or soxhlet set-up Beaker with stirrer Activator 4-Nitrophenyl 4-Nitrophenyl 4-Nitrophenyl chloroformate chloroformate chloroformate Amount of reagents Stoichiometric 3-fold excess (both base Stoichiometric and activator Solvent CH2CI2 CH3CN CH2CI2 Reaction time 2 hours 8 hours 2 hours Reaction 21 C 80 C 29 C
temperature Purification Extraction and Several precipitation / Extraction and precipitation recrystallization steps precipitation Side products 4-DMAP.HCI TEA.HCI NaCI
Excess TEA and activator Yield 95% 99% (including excess 97%
reagents) The crude yield of the activation reaction was calculated using Equation 2, as shown below:

Amount of Crude Product (g) % Crude Yield = X 100%
Theoretical amount of Activated PEG (g) Equation 2 Note that the amount of crude product theoretically includes traces of non-activated PEG, mono-activated PEG and di-activated PEG (desired product). In the case of the TEA promoted activation reactions, the crude product is additionally. mixed with non-negligible amounts of TEA.HCI as well as unreacted 4-nitrophenyl chloroformate, which could not be completely removed during the recrystallization / precipitation steps.
The degree of activation was calculated using Equation 3, as shown below:

Amount of p-nitrophenol generated by hydrolysis (g) Activation = X 100%
Theoretical amount of p-nitrophenol (g) Equation 3 Note that the amount of p-nitrophenol generated stems from the hydrolysis of the crude reaction product. The theoretical amount of p-nitrophenol expected is calculated based on the assumption that a 100% conversion of PEG into di-activated PEG has taken place.

Activation levels in excess of 100%, as are observed in the TEA-prompted activation reactions, can be explained by the persistent presence of unreacted excess 4-nitrophenyl chloroformate in the crude reaction product. This unreacted starting material will also produce 4-nitrophenol upon hydrolysis, and hence will add to the amount of 4-nitrophenol produced from the hydrolysis of the crude reaction product composed of unreacted PEG, mono-activated PEG and the desired di-activated PEG. Note that the presence of 4-nitrophenol, being a relatively strong organic acid, will result in aqueous solutions having low pH
values.

The very high yields observed for the TEA activation reactions are due to difficulties incurred in the purification process. TEA.HCI, as well as excess p-nitrophenyl chloroformate, are difficult to remove entirely from the reaction mixtures. Even though an extensive precipitation / recrystallization was performed to remove these impurities from the crude reaction product, non-negligible amounts persist. Moreover this extensive precipitation / recrystallization process usually results in a significant decrease in the yield of activated PEG

Some physical and chemical properties of the activated PEGs produced by the DMAP and TEA processes respectively, are provided in Table 2 below:
Table 2: Comparison of some physical and chemical properties of the PEGs produced by the DMAP and TEA procedure.
Properties DMAP procedure TEA procedure Solubility > 800 mg / ml Whatever the concentration, a precipitate is usually observed*
Melting point 53-55 C 54-55 C
Coloration White solid White solid water Yellow solution (deionized water) Limpid solution (deionized pH (220 mg/ml H2O) Solution takes the pH of Acidic pH = 2-3 deionized. water H=5.5 (in deionized water *The precipitate is composed mainly of unreacted 4-nitrophenyl chloroformate.

The activated PEGs produced by the DMAP procedure exhibit very good water solubility, with values exceeding 800 mg/ml.

The solubility in deionized water of the PEGs activated by the TEA process, could not be determined accurately because of the appearance of a precipitate during the dissolution of the crude product. The precipitate is composed mainly of unreacted 4-nitrophenyl chloroformate which could not be entirely removed from the crude reaction product during the precipitation / recrystallization steps.
Additionally, the presence of TEA.HCI in the crude reaction mixture will cause a phenomenon described as "salting out". This phenomenon causes a portion of the product itself to become' insoluble in deionized water and results in it precipitating out of the solution.

The crude product generated from the TEA-promoted activation process, isolated following repeated precipitation / recrystallization steps, is essentially composed of activated PEG but contains small amounts of the hydrochloric acid salt of TEA
(TEA.HCI) and unreacted p-nitrophenyl chloroformate. It is assumed that a non-negligible amount of the hydrochloric acid salt of TEA and unreacted p-nitrophenyl chloroformate remains trapped within the extensive network that constitutes activated PEG, and is consequently co-dissolved within this network.
Activated PEGs produced by the DMAP process generate aqueous solutions that adopt.the pH of the solvent and that have no discernible precipitate formation.
This is a direct indication of the high purity of the activated PEGs and confirms the absence of any DMAP hydrochloric acid salt (DMAP.HCI) which, in turn, is reflective of the efficiency of the purification and isolation steps of the process.
Crude activated PEGs produced by the TEA process generate substantially acidic aqueous solutions with pH values ranging between 2 and 3. This was to be expected in light of the possibility that the crude activated PEG product remains in the presence of 4-nitrophenyl chloroformate, which could not be entirely removed by the precipitation / recrystallization steps. When the crude activated PEG
product produced by the TEA procedure is dissolved in water, a portion of the persistent 4-nitrophenyl chloroformate is hydrolyzed into the strong organic acid 4-nitrophenol with the concomitant formation of HCI, which brings forth the observed acidic pH values.

A comparative study of the efficiency of the DMAP and TEA processes was carried out at room temperature in CH2CI2, using stoichiometric conditions. As is shown in Table 3, the DMAP activation process results in considerably higher activation levels over identical time intervals.

Table 3: Activation levels of crude PEG resulting from the DMAP and TEA
processes as a function of time.
De gree of Activation*
Reaction time min DMAP mediated activation TEA mediated activation 60.0% 32.0%
60 59.9% 34.5%
90 76.9% 31.7%
120 97.7% 31.3%
*Both the DMAP and TEA reagents were used at room temperature in CH2CI2 under stoichiometric conditions, using 4-nitrophenyl chloroformate as. the activator.

As becomes readily apparent from the results depicted in Table 3, the DMAP
mediated activation process is considerably more efficient than the TEA
mediated process. Essentially, the entire PEG is activated within 2 hours of starting the activation reactions, whereas approximately only 30% of the PEG is activated using the TEA mediated process.

The use of stoichiometric quantities of reagents greatly simplifies the purification 5 step. Additionally, the use of a stoichiometric amount of 4-nitrophenyl chloroformate assures that essentially all of the remaining non-reacted reagent is hydrolyzed during the extraction and precipitation steps, and will therefore not influence the quality of the final product.

The activation reactions were carried out for a given time and then stopped.
The 10 crude reaction mixtures were purified by repeated extraction and precipitation steps, and the product so-obtained was analyzed. To do this, a series of reactions were run over a 30, 60, 90 and a 120 minute period, using in one case DMAP and in another case TEA. The resulting products were subsequently analyzed for their degree of activation.

15 The results of another efficiency study, comparing the yields of activated PEG
obtained using the DMAP and TEA processes, are shown in Table 4.

Table 4: Yield of crude activated PEG obtained with the DMAP and TEA
processes as a function of time.
Yield Reaction time (min) DMAP mediated activation TEA mediated activation process pr9cess 57.8 78.9 60 95.8 87.7 90 87.5 83.2 120 93.3 80.8 *Both the DMAP and TEA reagents were used at room temperature in CH2CI2 under stoichiometric 20 conditions, using 4-nitrophenyl chloroformate as the activator.

As can be observed from Table 4, relatively similar yields are obtained for both activation procedures. The lower yield observed for the DMAP procedure, as a result of a 30 minute reaction, is due to a loss of crude product incurred during the extraction / precipitation steps. However, the isolated yields obtained for the TEA
process are misleading, due to the previously mentioned difficulties in effectively removing all of the unreacted 4-nitrophenyl chloroformate from the crude activated PEG product. The amount of crude activated PEG isolated from the TEA activation process contains persistent, non-negligible amounts of unreacted 4-nitrophenyl chloroformate, thus resulting in the observed higher yields. The presence of unreacted 4-nitrophenyl chloroformate is a reflection of a less efficient activation process when TEA is used. The activation process using DMAP is significantly more efficient and results in an essentially complete consumption of the 4-nitrophenyl chloroformate activating reagent. The only - significant side product' produced when using DMAP is its corresponding hydrochloric acid salt. This side product however, is efficiently removed from the crude activated PEG product by the extraction / precipitation steps.

The activation reactions were again carried out at room temperature in CH2CI2 using stoichiometric conditions. A series of reactions were run for 30, 60, 90 and 120 minutes, using in one case DMAP and in another case TEA, and were then analyzed for the amount of activated PEG produced.

The propensity of the activated PEGs produced by the TEA and DMAP processes towards gelification was subsequently investigated, and the results are shown in Table 5. A gelification index of zero is indicative of a gel remaining in a liquid state whereas a gelification index of one is indicative of a slightly viscous-liquid gel (remains in an essentially liquid state). Furthermore, a gelification index of two is indicative of a gelatinous gel that is very elastic and sticky, whereas an index of three is indicative of a soft gel that is slightly sticky and slightly elastic, and that reclaims its original form upon deformation. A gelification index of four describes a rigid and non-sticky gel that also reclaims its original form upon deformation. A
gelification index of four represents the desired physical state for such applications as hydrogel formation. Finally, a gelification index of five is indicative of a gum-like gel. The activated PEGs were subjected to the gelification conditions in a test tube over a 1-hour period.

Table 5: Gelification of crude activated PEG.
Gelification level DMAP mediated activation TEA mediated activated Time (min) 'process procqss Gelification could not be observed for any of the activated PEGs produced by the TEA mediated activation process. The solutions containing activated PEG
resulting from a 30, 60, 90 or a 120 minute activation reaction using TEA, did not display any discernable gelification and remained essentially in a liquid state. The absence of any perceptible gelification is a direct result of a low degree of activation of the crude activated PEGs produced by the TEA mediated activation process.

Gelification was observed for all of the activated PEGs produced by the DMAP
process. The solutions containing activated PEG generated from a 30, 60, 90 or a 120 minute activation reaction using DMAP resulted in the formation of gels ranging from soft to rigid. Activated PEGs produced from a 30 or 60 minute reaction result in the formation of soft gels that are slightly sticky and slightly elastic and that reclaim their original form upon deformation. Activated PEGs produced from a 90 or a 120 minute reaction result in the formation of rigid gels that are non-sticky and that also reclaim their original form upon deformation.
Furthermore, these gels have the desired physical state for such applications as hydrogel preparation. The improved physical state of the gels resulting from extended reaction times, is a direct consequence of an increased degree of activation.

The melting points of the activated PEGs are an indication of their degree of activation. As can be seen from Table 6, the activated PEGs produced by the DMAP procedure have melting points that are consistently lower than those produced by the TEA procedure.

Table 6: Melting points of activated PEGs produced by the DMAP and TEA
activation process.
Melting points ranges (OC
DMAP procedure TEA procedure Time min The melting point for non-activated PEG ranges between about 62-63 C. Since the melting points observed for activated PEGs produced via the TEA activation process are only slightly lower, this would be an indication of their physical similarity, in turn implying a low degree of activation. In the case of the TEA
activation process, the melting point observed for an activated PEG produced following a 30 minute activation reaction is identical to a PEG produced following a 120 minute activation reaction. This is in accordance with the results described in Table 3, which indicate a low degree of activation following a 30 minute reaction, with little or no change following a 120 minute reaction.

The melting points observed for activated PEGs produced via the DMAP
activation process are lower than those produced by the TEA process, which is indicative of a higher degree of activation. The activated PEGs produced following a 120 minute activation reaction using the DMAP process have a lower melting point than those produced following a 30 minute activation reaction. The lower melting point is an indication of an increased degree of activation over longer reaction times. Again, these results are corroborated by the results reported in Table 3, illustrating increased activation in going from a 30 minute to a 120 minute activation reaction.

The present invention provides for a process for the rapid activation of PEG.
The activation process is conveniently carried out at room temperature over a period of 2 hours, while in the presence of stoichiometric amounts of reagents. The activated PEGs of the present invention can be used to generate hydrogels by combining them with alkaline hydrolyzed soya solutions. The activated PEGs can also be used as linkers for resins, and they can be readily linked to proteins or reacted with enzyme surfaces.

EXPERIMENTAL
1. Gelification procedure a) Preparation of an 8 KDa activated PEG (PEG-(NPC)21 solution; (220 mg / mL).
Activated PEG (8 KDa) is removed from the refrigerator and is allowed to slowly warm up to room temperature, after which 1.65 g is dissolved in deionized water (4 mL, pH = 5.5) while stirring. The solution is stirred until complete dissolution is observed. If necessary, depending on the swelling of the activated PEG, the volume of deionized water is adjusted to 7.5 mL. Aliquots (500 L) are then added to a series of test tubes.

b) Preparation of a hydrolyzed soya solution; (120 mg / mL).

Hydrolyzed soya is removed from the refrigerator and is allowed to slowly warm to room temperature, after which 600 mg are placed in each of 5 test tubes (15 mL).
As depicted in Table 7 below, a NaOH solution (5 mL), having a different normality, is then added to each test tube. The resulting solutions are stirred until complete dissolution is observed.

Table 7: Preparation of hydrolyzed soya solutions using NaOH solutions of different normality.
Amount of hydrolyzed NaOH NaOH
sow (Mg) Normality (N) Volume mL
600 0.11 5 600 0.12 5 600 0.13 5 600 0.14 5 600 0.15 5 c) Hydrogel formation; coupling activated PEG [PEG-(N PC)21 to hydrolyzed soya.

A hydrolyzed soya solution (500 L) of a given normality is pipetted and a chronometer is started. At t = 10 sec, the hydrolyzed soya solution is added to a 10 test tube containing an activated PEG solution (500 L), prepared as previously described, while stirring using a vortex. The test tube containing the combined solution is then placed on its side so as to allow for hydrogel formation.
This experiment is repeated two more times using the same hydrolyzed soya solution.
The same procedure is carried out for each of the previously described 15 hydrolyzed soya solutions.

2. Preparation of an activated PEG using SO2C12 The following is an example of a general experimental process for the preparation of an activated PEG using sulfuryl chloride as the activating agent.

The reaction is carried at room temperature over a 2 hour period, in anhydrous 20 dichloromethane (CH2CI2).

Anhydrous S02C12 (1.565 L; 97% solution) is diluted in anhydrous CH2CI2 (25 mL). The diluted sulfuryl chloride solution is then transferred to a round-bottomed flask (500 mL) and cooled in an ice bath while stirring. To this cooled solution is then added a previously prepared DMAP solution (2.44 g of DMAP were dissolved in 5 mL of anhydrous CH2CI2) while stirring is continued.

PEG 8 KDa (36.36 g) is dissolved in anhydrous CH2CI2 (50 mL). The PEG
solution is then slowly added to the solution containing the sulfuryl chloride and DMAP reagents, kept in the ice bath under continuous stirring. Upon completion of the addition, the ice bath is removed and the reaction mixture stirred at room temperature for an additional 2 hours.

The reaction mixture is concentrated and the resulting crude solid product is extracted and precipitated with cold diethyl ether (500 mL). The suspension is then placed in a refrigerator (- 20 C) for a period of 30 minutes. The, suspension is vacuum filtered and the precipitate washed with additional diethyl ether (3 x 100 mL). The washed precipitate is then dried under vacuum.

3. Preparation of sodium PEGylate The following is an example of a general experimental process for the preparation of sodium PEGylate.

The reaction is carried at room temperature in anhydrous dichloromethane (CH2CI2) using stoichiometric amounts of reagents.

NaH (0.378 g of a 60% dispersion in mineral oil) was added to a double-necked round-bottomed flask equipped with a magnetic stirrer and a condenser. A CaCI2 tube was positioned on top of the condenser. The round-bottomed flask was then charged with anhydrous dichloromethane (50 ml).

PEG(-OH)2 8 kDa (36.36 g; 4.5 mmoles) was dissolved in anhydrous dichloromethane (50 mL) and the resulting solution was then added dropwise under vigorous stirring to the NaH suspension. The reaction mixture was continued to be stirred until no more hydrogen gas evolution could be observed, after which it was stirred for an additional hour.

The reaction mixture was filtered or centrifuged, and the resulting dichloromethane solution was concentrated. The resulting crude product was treated with anhydrous diethyl ether (100 mL), resulting in the precipitation.
of PEG(-ONa)2. The resulting precipitate was washed with additional portions of diethyl ether (3 x 100 mL) and dried under vacuum, allowing for the isolation of PEG(-ONa)2 as a white solid (35.8 g; 97% yield).

4. Preparation of activated sodium PEGylate The following is an example of a general experimental process for the preparation of activated sodium PEGylate.

The reaction is carried at 29 C over a 2 hour period, in anhydrous dichloromethane (CH2CI2).

Anhydrous S02CI2 (2.348 mL) is diluted in anhydrous CH2CI2 (25 mL). The diluted sulfuryl chloride solution is then transferred to a double-necked round-bottomed flask (50 mL) equipped with a magnetic stirrer and a condenser. A CaCl2 tube was positioned on top of the condenser. The solution was slowly heated to 29 C, and the temperature was continued to be closely monitored.

PEG(-ONa)2 8 kDa (36.36 g; 4.5 mmoles) was dissolved in anhydrous dichloromethane (50 mL) and the resulting solution was then added dropwise under vigorous stirring to the S02C12 solution. The reaction mixture was continued to be stirred for an additional 2 hours at 29 C.

The reaction mixture was precipitated using 5 volumes of diethyl ether cooled to 4 C. The resulting suspension was then placed in a refrigerator (- 20 C) for a period of 30 minutes. The suspension is vacuum filtered and the precipitate washed with additional cold diethyl ether (3 x 75 mL). The washed precipitate was then recrystallized in a dichloromethane / diethyl ether solvent system.

5. Preparation of an activated PEG using p-nitrophenyl chloroformate.

The following is an example of a general experimental process for the preparation of an activated PEG using p-nitrophenyl chloroformate as the activating agent.
The reaction is carried at room temperature over a 2 hour period, in anhydrous dichloromethane (CH2CI2).

PEG 8 KDa (363.36 g; 45 mmoles) was dissolved in anhydrous CH2CI2 (500 mL), and p-nitrophenyl chloroformate (19.63 g) was dissolved in anhydrous CH2CI2 (50 mL). Both solutions were then added to a reaction vessel (8.0 L) and stirred vigorously for about one 1 minute. To this solution was then added a previously prepared DMAP solution (12.22 g of DMAP were dissolved in 50 mL of anhydrous CH2CI2) while stirring is continued. The reaction mixture was then stirred for an additional 2 hours at room temperature.

The reaction mixture was concentrated and precipitated using diethyl ether (2.0 L) cooled to 4 C. The resulting suspension was then placed in a refrigerator (-C) for a period of 30 minutes. The suspension is vacuum filtered and the precipitate washed several times with additional cold diethyl ether. The washed precipitate was then suspended in water, stirred vigorously for about 30 minutes, and vacuum filtered. The so-obtained yellow-like filtrate was then extracted (3x) with dichloromethane and the combined solvent fractions filtered over Na2SO4.
The filtrate was concentrated and the resulting product was precipitated under vigorous stirring using cold diethyl ether. The so-obtained PEG(NPC)2 was then filtered, washed with diethyl ether, and dried under vacuum.

The terms and descriptions used herein are preferred embodiments set forth by way of illustration only, and are not intended as limitations on the many variations which those of skill in the art will recognize to be possible in practicing the present invention.

REFERENCES

1. Mehvar, R.; J. Pharm. Pharmaceut. Sci. 2000, 3(1), 125.
2. Beauchamp, C. 0.; Gonias, S. H.; Menapace, D. P.; Pizzo, S. V.; Anal.
Biochem. 1983, 131, 25.
5 3. Nashimura, H.; Takahashi, K.; Sakurai, K.; Fujinuma, Y.; Imamura, Y.;
Ooba, M.; Inada, Y. Life Sci. 1983, 33, 1467.
4. Delgado, C.; Patel, J. N.; Francis, G. E.; Fisher, D. Biotechnol. App!.
Biochem. 1990, 12, 119.
5. Wirth, P.; Souppe, J.; Tritsch, D.; Biellmann, J.-F. Bioorg. Chem. 1991, 19, 10 133.
6. Veronese, F. M.; Largajolli, R.; Boccu, E.; Benassi, C. A.; Schiavon, O.
App!. Biochem. Biotechnol. 1985, 11, 141.
7. Sartore, L.; Caliceti, P.; Schiavon, 0.; Veronese, F. M. App!. Biochem.
Biotechnol 1991, 27, 45.
15 8. Anderson, W. L.; Tomasi, T. B. J. Immunol. Methods 1988, 109, 37.
9. Zalipsky, S.; Barany, G. J. Bioact. Compat. Polym. 1990, 5, 227.
10. Fortier, G. F.; Laliberte, M. Biotechnol. App!. Biochem.1993, 17, 115.

Claims (46)

1. A process for preparing a bis-activated polyethylene glycol, the process comprising reacting polyethylene glycol with an activator under stoichiometric conditions in the presence of dimethylaminopyridine (4 - DMAP) as illustrated by equation 1A
below:
H(O-CH2-CH2)n-OH + 2Y-Q-X + 2W T = Y-Q-O(CH2-CH2-O)n-Q-Y + 2W-T-HX
Equation 1A
wherein polyethylene glycol has the formula H(O-CH2-CH2)n-OH
the activator has the formula Y-Q-X, wherein X and Y independently are selected from the group consisting of CI, Br, I, mesylates, tosylates and phenoxides, and Q is selected from the group consisting of -SO2-, -C(O)-, -C(O)(CHR1)tSO2-, -SO2(CHR1)tSO2-, -SO2O(CHR1)tOSO2-, -C(O)-O-(CHR1)t-CR2=CR3-(CHR4)t-O-C(O)-, and -SO2-O-(CHR1)t-CR2=CR3-(CHR4)r-O-SO2-;
wherein R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyi group, a lower branched alkyl group, an aryl group, and an aralkyl group; and t is an integer ranging from 1 to 3; and dimethyiaminopyridine (4 - DMAP) has the formula W - T

the bis-activated polyethylene glycol has the formula Y-Q-O-(CH2-CH2-O)n-Q-Y, wherein Y and Q are as defined above, and n is an integer ranging from 4 to 800.
2. A process as defined in claim 1, wherein n is an integer ranging from 65 to 800.
3. A process as defined in claim 1 or 2, wherein R1, R2, R3, and R4 are independently selected from the group consisting of H, a methyl group, an ethyl-group, an isopropyl group, and a propyl group.
4. A process as defined in any one of claims 1 to 3, wherein Q is selected from the group consisting of SO2, CO-O-CH2-CH=CH-CH2-O-CO, COCH2SO2, C(O), and SO2CH2CH2SO2.
5. A process as defined in any one of claims 1 to 4, wherein Y-Q-X is selected from the group consisting of 4-O2N-Ph-O-CO-CI, CI-SO2-O-CH2-CH2-O-SO2-CI, CI-SO2-O-CH2-CH2-O-CO-CI, CI-CO-O-CH2-CH=CH-CH2-O-CO-CI, CI-SO2-CI, CI-CO-CH2-SO2-CI, 2-O2N-Ph-O-CO-CI, Ph-O-CO-CI, and Z b Ph-O-CO-CI, wherein Ph is a phenyl group, Z is selected from the group consisting of CI, Br, I, and -CN, and b is an integer ranging from 1 to 3.
6. A process as defined in any one of claims 1 to 5, wherein the process is carried out in an organic solvent.
7. A process as defined in claim 6, wherein said organic solvent is an aprotic solvent.
8. A process as defined in claim 7, wherein the aprotic solvent has a boiling point ranging from about 35°C to about 230°C.
9. A process as defined in claim 7, wherein said aprotic solvent is selected from the group consisting of DMSO, DMF, acetonitrile, nitromethane, HMPA, acetone, acetic anhydride, pyridine, o-dichlorobenzene, chlorobenzene, benzene, toluene, xylene, methylene chloride, carbon tetrachloride, THF, dioxane, ethyl acetate, DME, and carbon disulfide.
10. A process as defined in claim 9, wherein the aprotic solvent is methylene chloride.
11. A process as defined in any one of claims 1 to 10, wherein said process is carried out at temperatures ranging from about 20°C to about 30°C.
12. A process as defined in claim 11, wherein said process is carried out at room temperature.
13. A process for preparing a bis-activated polyethylene glycol having the formula:
Y-Q-O-(CH2-CH2-O) n-Q-Y

wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO- , and SO2-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;
the process consisting essentially of reacting under stoichiometric conditions a polyethylene glycol having the formula:

H-(O-CH2-CH2-)n-OH
wherein n is an integer between 4 and 800;

with an activator having the formula of Y-Q-X;
wherein X and Y independently are selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxy group; and Q is selected from the group consisting Of S02, CO(CHR,)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1),SO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO-, and SO2-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

wherein (NR5R6)c is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.
14. The process of claim 13, wherein the activator is selected from the group consisting of CI-CO-O-Ph-NO2, CI-SO2-O-CH2-CH2-O-SO2-CI, CI-SO2-O-CH2-CH2-O-CO-CI, and CI-CO-O-CH2-CH=CH-CH2-O-CO-CI.
15. The process of claim 13 or 14, wherein said process is carried out at temperatures ranging from about 20°C. to about 30° C.
16. The process of any one of claims 13 to 15, wherein the aromatic nitrogen-containing heterocyclic base is 4-dimethylaminopyridine.
17. The process of claim 16, wherein reacting the polyethylene glycol with the activator is in the presence of six molar equivalents or less of 4-dimethylaminopyridine.
18. A process for preparing a bis-activated polyethylene glycol having the formula:
Y-Q-O-(CH2-CH2-O),-Q-Y

wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR,)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO-, and SO2-O-(CHR1)r-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;
the process consisting essentially of reacting a polyethylene glycol having the formula:
H-(O-CH2-CH2-)n-OH

wherein n is an integer between 4 and 800;

with an activator having the formula of Y-Q-X;
wherein X and Y are different and independently selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO-, and SO2-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

wherein (NR5R6)c is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.
19. The process of claim 18, wherein the activator is 4-nitrophenyl chloroformate.
20. The process of claim 18, wherein the aromatic nitrogen-containing heterocyclic base is 4-dimethylaminopyridine.
21. The process of claim 18, wherein reacting the polyethylene glycol with the activator is under stoichiometric conditions.
22. The process of claim 18, wherein at least one of X and Y is a halide group.
23. The process of claim 21, wherein at least one of X and Y is a halide group.
24. A process for preparing a bis-activated polyethylene glycol having the formula:
Y-Q-O-(CH2-CH2-O)n-Q-Y

wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO- , and SO2-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

the process consisting essentially of reacting a polyethylene glycol having the formula:
H-(O-CH2-CH2-)n-OH

wherein n is an integer between 4 and 800;
with an activator having the formula of Y-Q-X;
wherein X and Y independently are selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group, provided that at least one of X
and Y is a halide group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO- , and SO2-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

wherein (NR5R6)c is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.
25. The process of claim 24, wherein the activator is selected from the group consisting of CI-CO-O-Ph-NO2, CI-SO2-O-CH2-CH2-O-SO2-CI, CI-SO2-O-CH2-CH2-O-CO-CI, and CI-CO-O-CH2-CH=CH-CH2-O-CO-CI.
26. The process of claim 24, wherein the aromatic nitrogen-containing heterocyclic base is 4-dimethylaminopyridine.
27. The process of claim 24, wherein reacting the polyethylene glycol with the activator is under stoichiometric conditions.
28. The process of claim 24, wherein reacting the polyethylene glycol with the activator is at room temperature.
29. The process of claim 28, wherein X and Y are different.
30. A process for preparing a bis-activated polyethylene glycol having the formula:
Y-Q-O-(CH2-CH2-O)n-Q-Y

wherein n is an integer between 4 and 800;

Y is selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO-, and SO2-O-(CHR1)t-CR2=CR3-(CHR4)t-O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3 and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;
the process consisting essentially of reacting a polyethylene glycol having the formula:
H-(O-CH2-CH2-)n OH

wherein n is an integer between 4 and 800;

with an activator having the formula of Y-Q-X;
wherein X and Y independently are selected from the group consisting of a halide group, a mesyl group, a tosyl group, an imidazolyl group, an N-hydroxy-succinimidyl group, a phenoxyl group, and a substituted phenoxyl group; and Q is selected from the group consisting Of SO2, CO(CHR1)tSO2, CO-O-(CHR1)t-O-SO2, C(O), SO2(CHR1)tSO2, SO2-O-(CHR1)t-O-SO2, CO-O-(CHR1)t-CR2=CR3-(CHR4)t-O-CO- , and SO2-O-(CHR1)t-CR2=CR3-(CHR4), -O-SO2, wherein t is 1, 2, or 3; and R1, R2, R3, and R4 are independently selected from the group consisting of H, a lower alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group;

at a temperature range between about 20° C. and about 30° C., and in the presence of a solvent and an aromatic nitrogen-containing heterocyclic base having the formula:

wherein (NR5R6)c is located either in the ortho or para position;

R5 and R6 are independently selected from the group consisting of a lower straight alkyl group, a lower branched alkyl group, an aryl group, and an aralkyl group; and c is 1 or 2;

to produce said bis-activated polyethylene glycol.
31. The process of claim 30, wherein the activator is selected from the group consisting of CI-CO-O-Ph-NO2, CI-SO2-O-CH2-CH2-O-SO2-CI, CI-SO2-O-CH2-CH2-O-CO-CI, and CI-CO-O-CH2-CH=CH-CH2-O-CO-CI.
32. The process of claim 30, wherein the aromatic nitrogen-containing heterocylic base is 4-dimethylaminopyridine.
33. The process of claim 30, wherein X and Y are different.
34. The process of claim 33, wherein reacting the polyethylene glycol with the activator is under stoichiometric conditions.
35. The process of claim 34, wherein at least one of X and Y is a halide group.
36. An acitvated polyethylene glycol having a general structure as shown below:

Y-Q-O-(CH2-CH2-O)n-Q-Y

wherein Q is selected from the group consisting of -SO2-, -CO(CHR1)tSO2-, -CO-, -SO2(CHR1)tSO2-, -SO2-O-(CHR1),O-SO2, >PO, -CO-O-(CHR1)tCR2-CR3-(CHR4)t-O-CO-, and -SO2-O-(CHR1)tCR2=CR3-(CHR4)t-O-SO2-, wherein "t" is an integer ranging from 1 to 3 and wherein R1, R2, R3 and R4 are either identical or different and are selected from the group consisting of hydrogen, lower alkyl, lower branched alkyl, aryl and aralkyl;

"n" is an integer ranging from 4 to 800; and "Y" is selected from the group consisting of H, CI, Br, I, mesylates, tosylates and phenoxides.
37. An activated polyethylene glycol as defined in claim 36, wherein Q is selected from the group consisting of -SO2-, -CO-O-CH2-CH=CH-CH2-O-CO-, COCH2SO2-, -CO-, and -SO2CH2CH2SO2-.
38. An activated polyethylene glycol as defined in claim 37, having the structure shown below by Formula 4:

wherein "n" is an integer ranging from 4 to 800.
39. An activated polyethylene glycol as defined in claim 37, having the structure shown below by Formula 5:

wherein "n" is an integer ranging from 4 to 800.
40. An activated polyethylene glycol as defined in claim 37, having the structure shown below by Formula 6:

wherein "n" is an integer ranging from 4 to 800.
41. An activated polyethylene glycol as defined in claim 37, having the structure shown below by Formula 7:

wherein "n" is an integer ranging from 4 to 800.
42. An activated polyethylene glycol as defined in any one of claims 36 to 41, having a molecular weight ranging from 200 to 35 000 Da.
43. An activated polyethylene glycol as defined in claim 42, susceptible of reacting with functional groups selected from the group consisting of hydroxyl groups, amine groups and thiol groups, resulting in the formation of bio-polymers.
44. An activated polyethylene glycol as defined in claim 43, wherein said functional groups are derived from the group consisting of peptides, proteins, saccharides, polysaccharides, and oligonucleotides.
45. An activated polyethylene glycol as defined in claim 43, wherein the bio-polymers are used in chemical, food, cosmetical, cosmeceutical, pharmaceutical and dermopharmaceutical applications.
46. An activated polyethylene glycol as defined in claim 36, wherein "n" is an integer ranging from 65 to 800.
CA2457876A 2001-08-22 2002-08-22 Process for the preparation of activated polyethylene glycols Expired - Fee Related CA2457876C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31380101P 2001-08-22 2001-08-22
US60/313,801 2001-08-22
PCT/CA2002/001306 WO2003018665A1 (en) 2001-08-22 2002-08-22 Process for the preparation of activated polyethylene glycols

Publications (2)

Publication Number Publication Date
CA2457876A1 CA2457876A1 (en) 2003-03-06
CA2457876C true CA2457876C (en) 2011-10-11

Family

ID=23217202

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2457876A Expired - Fee Related CA2457876C (en) 2001-08-22 2002-08-22 Process for the preparation of activated polyethylene glycols

Country Status (6)

Country Link
US (1) US7125558B2 (en)
EP (1) EP1419191B1 (en)
AT (1) ATE376020T1 (en)
CA (1) CA2457876C (en)
DE (1) DE60223047T2 (en)
WO (1) WO2003018665A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1373376B1 (en) * 2001-03-08 2006-08-23 Bioartificial Gel Technologies Inc. Hydrogel attached to backing and method for making same
DE60223047T2 (en) 2001-08-22 2008-07-24 Bioartificial Gel Technologies Inc., Montreal PROCESS FOR PREPARING ACTIVATED POLYETHYLENE GLYCOLS
EP1680148A1 (en) * 2003-10-21 2006-07-19 Bioartificial Gel Technologies Inc. Hydrogel-containing medical articles and methods of using and making the same
US7351787B2 (en) * 2004-03-05 2008-04-01 Bioartificial Gel Technologies, Inc. Process for the preparation of activated polyethylene glycols
EP1865920A1 (en) * 2005-04-04 2007-12-19 Bioartificial Gel Technologies Inc. Prevention and treatment of radiation dermatitis
EP1865982A1 (en) * 2005-04-06 2007-12-19 Bioartificial Gel Technologies Inc. Hydrogel composition for modulation of topical inflammatory response
US8586078B2 (en) * 2005-12-05 2013-11-19 Rba Pharma Inc. Emulsion-containing medical articles

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463862A (en) 1964-05-21 1969-08-26 Geneva Carol Mazza Albumin containing comsmetic lotion
US4464468A (en) 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
IL47468A (en) 1975-06-12 1979-05-31 Rehovot Res Prod Process for the cross-linking of proteins using water soluble cross-linking agents
US4002531A (en) 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
CH625702A5 (en) 1977-01-18 1981-10-15 Delalande Sa
US4264155A (en) 1979-07-09 1981-04-28 Opticol Corporation Collagen contact lens
USRE33997E (en) 1981-02-09 1992-07-14 Allergan, Inc. Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses
US4388428A (en) 1981-07-20 1983-06-14 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses
FR2565160B1 (en) 1984-06-04 1987-03-06 Essilor Int PROCESS FOR PRODUCING A FLEXIBLE CONTACT LENS OF NATURAL PROTEIN POLYMER (S), AND CONTACT LENS THUS OBTAINED
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4752627A (en) 1986-08-13 1988-06-21 Michael Froix Clouding-resistant contact lens compositions
US5114627A (en) 1986-10-16 1992-05-19 Cbs Lens Method for producing a collagen hydrogel
EP0326618A1 (en) 1987-03-04 1989-08-09 Nippon Hypox Laboratories Incorporated Medicinal composition containing albumin as carrier and process for its preparation
FR2617763B1 (en) 1987-07-07 1989-12-01 Essilor Int METHOD OF MANUFACTURING CONTACT LENS IN A NATURAL PROTEIN POLYMER, BY MOLDING BEFORE CROSS-LINKING
MX12394A (en) 1987-07-23 1993-12-01 Ciba Geigy Ag PROCEDURE FOR OBTAINING POLYETHYLENE GLYCOL CARBAMATES.
US5214131A (en) 1988-05-06 1993-05-25 Sumitomo Pharmaceuticals Company, Limited Polyethylene glycol derivatives, modified peptides and production thereof
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5342940A (en) 1989-05-27 1994-08-30 Sumitomo Pharmaceuticals Company, Limited Polyethylene glycol derivatives, process for preparing the same
US5286637A (en) 1989-08-07 1994-02-15 Debiopharm, S.A. Biologically active drug polymer derivatives and method for preparing same
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
JP3051145B2 (en) 1990-08-28 2000-06-12 住友製薬株式会社 Novel polyethylene glycol derivative modified peptide
US5235028A (en) 1990-08-31 1993-08-10 University Of Minnesota Polyethylene glycol derivatives for solid-phase applications
US5545698A (en) 1990-08-31 1996-08-13 University Of Minnesota Polyethylene glycol derivatives for solid-phase applications
US5229366A (en) 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5281698A (en) * 1991-07-23 1994-01-25 Cetus Oncology Corporation Preparation of an activated polymer ester for protein conjugation
IT1260468B (en) 1992-01-29 1996-04-09 METHOD FOR MAINTAINING THE ACTIVITY OF PROTEOLYTIC ENZYMES MODIFIED WITH POLYETHYLENGLYCOL
US5284974A (en) * 1992-08-11 1994-02-08 Monsanto Company Process for the preparation of thioacetamide
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5298643A (en) 1992-12-22 1994-03-29 Enzon, Inc. Aryl imidate activated polyalkylene oxides
US5349001A (en) 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
JP3351476B2 (en) 1993-01-22 2002-11-25 三菱化学株式会社 Phospholipid derivatives and liposomes containing the same
US5321095A (en) 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
US5298410A (en) 1993-02-25 1994-03-29 Sterling Winthrop Inc. Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
US5605976A (en) 1995-05-15 1997-02-25 Enzon, Inc. Method of preparing polyalkylene oxide carboxylic acids
US5643575A (en) * 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
AU1060495A (en) 1993-12-01 1995-06-19 Universite Du Quebec A Montreal Albumin based hydrogel
US5650234A (en) * 1994-09-09 1997-07-22 Surface Engineering Technologies, Division Of Innerdyne, Inc. Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
DE69624581T2 (en) 1995-04-14 2003-05-15 Kazunori Kataoka POLYETHYLENE OXIDES WITH A SACCHARIDE GROUP AT ONE END AND ANOTHER FUNCTIONAL GROUP AT THE OTHER END, AND METHOD FOR THE PRODUCTION THEREOF
US6214966B1 (en) 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
AU7275698A (en) 1998-05-01 1999-11-23 Procter & Gamble Company, The Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
DE19903655A1 (en) 1999-01-29 2000-08-10 Beiersdorf Ag Hydrogel comprising protein or enzyme bonded to PEG via urea groups, useful as a dressing for wounds and burns
US6348558B1 (en) * 1999-12-10 2002-02-19 Shearwater Corporation Hydrolytically degradable polymers and hydrogels made therefrom
EP1280849B1 (en) 2000-04-04 2006-08-23 Bioartificial Gel Technologies Inc. Process for the preparation of proteinbased hydrogels
EP1373376B1 (en) 2001-03-08 2006-08-23 Bioartificial Gel Technologies Inc. Hydrogel attached to backing and method for making same
EP1423093A4 (en) * 2001-04-23 2005-11-30 Wisconsin Alumni Res Found Bifunctional-modified hydrogels
DE60223047T2 (en) 2001-08-22 2008-07-24 Bioartificial Gel Technologies Inc., Montreal PROCESS FOR PREPARING ACTIVATED POLYETHYLENE GLYCOLS

Also Published As

Publication number Publication date
US20050080206A1 (en) 2005-04-14
EP1419191B1 (en) 2007-10-17
WO2003018665A1 (en) 2003-03-06
ATE376020T1 (en) 2007-11-15
US7125558B2 (en) 2006-10-24
DE60223047T2 (en) 2008-07-24
EP1419191A1 (en) 2004-05-19
CA2457876A1 (en) 2003-03-06
DE60223047D1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
AU2010321882B2 (en) Salt form of a multi-arm polymer-drug conjugate
KR100225746B1 (en) Water soluble active sulfones of poly(ethylene glycol)
ES2831379T3 (en) Polymeric derivatives for selective protein modification
EP2010592B1 (en) Method for preparing multi-arm poly(ethylene glycol) amines
US7504477B2 (en) Polyalkylene glycol acid additives
KR100653153B1 (en) Sterically hindered derivatives of water soluble polymers
US5414135A (en) Vinyl sulfone coupling of polyoxyalkylenes to proteins
JP4877225B2 (en) Polyoxyalkylene derivatives
US20060276618A1 (en) Activated forms of water-soluble polymers
JP2005508421A (en) Branched polymers and their conjugates
EP1976896B1 (en) High efficiency method of preparing polyalkylene oxide carboxylic acids
CA2457876C (en) Process for the preparation of activated polyethylene glycols
EP0274998A2 (en) Resin support for solid phase peptide synthesis
JP3399100B2 (en) Oxyalkylene derivative
JPS63199704A (en) Resin for solid phase synthesis of peptide and synthesis thereof
WO2006097694A2 (en) Peptide synthesis supported by a soluble polymer
KR20050017774A (en) Novel Y-PEG Derivatives and the preparation method thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170822